Cardiovascular Diseases

Earn up to 3 CPD points per module

American College of Cardiology Congress Update 2025

Clinical update – A focus on direct oral anticoagulants (DOACs)

Cardiovascular complications of autoimmune rheumatic diseases

A polypill conundrum – Optimising cardiovascular risk management

New horizons in ischaemic stroke management and prevention

CARE – The cardiovascular and diabetes forum for GPs

What is new? European Association for the Study of Diabetes (EASD) 2024 Congress

What is new? European Society of Cardiology (ESC) Congress 2024

Stroke prevention in atrial fibrillation – How can we do better?

American College of Cardiology Update 2024

The EMPEROR clinical trials – Further guidance for today’s clinical practice

Combination therapy in dyslipidaemia – A practical approach

Breaking through the complexity of managing type 2 diabetes

European Society of Cardiology (ESC) Congress 2023

Type 2 diabetes and ASCVD

Treating and caring for our queen of hearts women and heart disease – Local experience and issues of care

Women and Cardiovascular Disease – a focus on heart failure trials

Lipid-lowering therapies – strengths, weaknesses, opportunities, threats

Breaking through the complexity of diabetes management and improving cardiovascular health through lipid management

Primary prevention of diseases of ageing – Use the benefits of menopausal hormone therapy

American College of Cardiology and World Heart Federation Update 2023

Treating dyslipidaemia and hypertension – A practical clinical approach

Chronic illness and Ramadan fasting – Optimal management for patients intending to fast

Treating hypercholesterolaemia – too little, too late

Cardiometabolic syndrome – new approaches

Heart failure management in 2023 – Variety and recovery

Is lower better? LDL Cholesterol in perspective

The Atrial Fibrillation (AF) avalanche

Women and cardiovascular disease – how different is the clinical course and outcome

European Society of Cardiology (ESC) 2022

From science to clinical practice – lessons from REWIND

Protecting the cardiac patient post-MI

Managing LDL-cholesterol after an acute coronary event

Anticoagulation in the patient with atrial fibrillation who suffers a stroke

The heart and diabetes – Is pre-diabetes a treatable entity?

Rewinding cardiovascular risks

American College of Cardiology Update 2022

Hypertension management in primary care

Hypertension update – Integrating home monitoring with clinical care – (Clinical lunch chat on-demand)

Recognising colchicine role in cardiovascular disease prevention

COVID-19 and Cardiovascular Disease

What’s new in atrial fibrillation?

COVID-19 and Thrombosis

New approaches to residual atherosclerosis risk

Fabry disease and the heart

Dyslipidaemia – getting to lower LDL targets safely

Current diagnosis and management of heart failure (HF) with reduced ejection fraction (HFrEF)

Angina: A missed medical opportunity

A new decade for patients with atrial fibrillation

From clinical hypothesis to a diagnosis of Fabry disease

American College of Cardiology Update 2021

Optimising patient care in atrial fibrillation

European Society of Cardiology (ESC) Congress 2021

Heart Failure – New Guidelines, New Treatments

Fabry Disease and the kidney

Heart failure update